Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, The Golden Road Kratom received an FDA Warning Letter on May 15, 2020, regarding products classified as drugs under FDA regulations. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information, though the drug classification suggests potential issues related to marketing claims, manufacturing standards, or product safety. The warning was issued under FDA's drug regulatory authority, indicating the agency determined the company's kratom products were being marketed or manufactured in violation of applicable drug regulations.